Glysopep

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameGlysopep
Drug Alias Nameglycopeptide P-selectin inhibitor (Selexys)
ClassificationSmall molecules > Heterocyclic drugsDiagnostic agent (In vivo)
Mechanisms of ActionP-selectin inhibitors
TargetsP-selectin
Therapy Area/IndicationsInflammationVenous ThrombosisCoronary Restenosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesReprixys Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesReprixys Pharmaceuticals Corp
Active IndicationsN/A
Inactive IndicationsInflammationVenous ThrombosisCoronary Restenosis

Other Information

ATC CodeN/A
Related LinksN/A